Impact of zanamivir treatment on productivity, health status and healthcare resource use in patients with influenza. Zanamivir Study Group (Q74186218)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947341%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Impact of zanamivir treatment on productivity, health status and healthcare resource use in patients with influenza. Zanamivir Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947341%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

F Y Aoki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947341%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

D M Fleming

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947341%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A D Griffin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947341%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

L A Lacey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947341%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

S Edmundson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947341%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947341%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947341%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947341%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947341%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

187-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10947341%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections

9 November 2019

cites work

1 reference

12 December 2020

The swine-influenza decision

1 reference

12 December 2020

Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group

1 reference

12 December 2020

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

12 December 2020

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

A pharmacoeconomic model for the treatment of influenza.

1 reference

12 December 2020

Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium

1 reference

12 December 2020

French economic evaluations of influenza and influenza vaccination

1 reference

12 December 2020

Influenza. The role of burden-of-illness research

1 reference

12 December 2020

Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes.

1 reference

12 December 2020

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

12 December 2020